共 4 条
Lack of evidence to support the association of polymorphisms within the alpha- and beta-secretase genes (ADAM10/BACE1)
被引:11
|作者:
Laws, S. M.
[1
,2
]
Eckart, K.
[2
]
Friedrich, P.
[2
]
Kurz, A.
Foerstl, H.
Riemenschneider, M.
[2
]
机构:
[1] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Sir James McCusker Alzheimers Dis Res Unit, Ctr Excellence Alzheimers Dis Res & Care, Joondalup, WA 6027, Australia
[2] Tech Univ Munich, Dept Psychiat & Psychotherapy, Lab Neurochem & Neurogenet, Munich, Germany
关键词:
Alzheimer's disease;
Genetics;
BACE1;
ADAM10;
APP;
Beta-amyloid;
AMYLOID PRECURSOR PROTEIN;
ALZHEIMERS-DISEASE;
CLEAVAGE;
D O I:
10.1016/j.neurobiolaging.2009.02.023
中图分类号:
R592 [老年病学];
C [社会科学总论];
学科分类号:
03 ;
0303 ;
100203 ;
摘要:
Cleavage of the amyloid precursor protein (APP) occurs through either an amyloidogenic or a non-amyloidogenic pathway. The first results in the generation of beta-amyloid (A beta) and is initiated through cleavage by the beta-site amyloid beta A4 precursor protein-cleaving enzyme 1 (BACE1). The second precludes the formation of A beta through cleavage by alpha-secretase, an enzyme's activity demonstrated in a disintegrin metalloproteinase, ADAM10. To assess the contribution of variants in the BACE1 and ADAM1 0 genes we used a detailed fine mapping approach. Genotyping of 11 single nucleotide polymorphisms covering the complete BACE1 gene, and 27 covering the entire ADAM10 gene, revealed no single-marker or haplotypic association with AD. We conclude that, in this present study, neither ADAM1 0 nor BACE1 present with any evidence to suggest that they are major candidate genes involved in conferring risk for AD. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:541 / 543
页数:3
相关论文